Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The largest NHS-based centre to identify genetic causes of heart disease has welcomed its 10,000th patient. Founded by Oxford University and NHS staff, the Oxford Medical Genetics Laboratory at the Churchill Hospital began its cardiac genetic testing service in 2003 and was the first accredited NHS diagnostic genetic testing service for inherited cardiac conditions (ICC) in the UK.

The Churchill Hospital © Steve Daniels [CC BY-SA 2.0 (http://creativecommons.org/licenses/by-sa/2.0)], via Wikimedia Commons

The service was developed in partnership with Professor Hugh Watkins from the University of Oxford and the Oxford ICC clinical team and today is a national and international service that has been at the forefront of developing and implementing faster, cheaper, more reliable and efficient genetic tests for the benefit of NHS patients in the UK.

Read more ...

Similar stories

Multi-partner 'OpenMind' consortium to develop technology for new generation of neurostimulation devices

General Research

Investigators at the University of Oxford, University of California San Francisco (UCSF), Brown University and the Mayo Clinic have joined forces to develop open-source technology platforms for a new generation of neurostimulation devices that not only provide stimulation to the brain but also sense, record, and stream brain activity.

Why we must expand newborn screening

General Research

Professor Laurent Servais of the Department of Paeditrics writes for the Oxford Science Blog on why it is important that we become much more efficient in the diagnosis of treatable conditions and in the treatment of these diseases.

New method for cost-effective genome-wide DNA methylation analysis

General Research

Ludwig Cancer Research team build on its TAPS method to develop an alternative to costly whole-genome sequencing for the detection of DNA methylation.

Azithromycin not effective against COVID-19, trial confirms

Clinical Trials General Research

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.